Blog

1 July 2015 - Novo Nordisk today announced that the company has decided to cease distribution of its once-daily basal insulin ...

[:content [\8 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \N \e \a \r \l \y \space \8 \5 \% \space \o \f \space \n \e \w \space \d \r \u \g \s \space \i \n \space \G \e \r \m \a \n \y \space \t \h \a \t \space \w \e \r \e \space \a \p \p \r \o \v \e \d \space \i \n \space \2 \0 \1 \1 \space \f \o \r \space \o \u \t \p \a \t \i \e \n \t \s \space \c \o \v \e \r \e \d \space \b \y \space \p \u \b \l \i \c " ..."]]

[:content [\L \i \s \d \e \x \a \m \f \e \t \a \m \i \n \e \  \d \i \m \e \s \y \l \a \t \e \space \( \E \l \v \a \n \s \e \) \space \w \a \s \space \a \p \p \r \o \v \e \d \space \b \y \space \t \h \e \space \E \u \r \o \p \e \a \n \space \C \o \m \m \i \s \s \i \o \n \  \i \n \space \M \a \r \c \h \space \2 \0 \1 \3 \space \a \s \space \p \a \r \t \space \o \f \space \a \n \space \o \v \e \r \a \l \l \space \t \h \e \r \a \p \e \u \t \i \c \space \s \t \r \a \t \e \g \y \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t " ..."]]

Sucroferric oxyhydroxide (trade name Velphoro) has been available since August 2014 for use by adults with chronic renal failure undergoing hemodialysis or peritoneal ...

The fixed combination of the drugs dapagliflozin and metformin (Xigduo) has been approved since January 2014 for adults with type ...

[:content [\C \o \n \s \t \e \l \l \a \space \i \s \space \t \h \e \space \f \i \r \s \t \space \a \n \d \space \o \n \l \y \space \p \r \o \d \u \c \t \space \a \p \p \r \o \v \e \d \space \i \n \space \t \h \e \space \E \U \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \I \B \S \- \C \space \i \n \space \a \d \u \l \t \s \space \a \n \d \space \h \a \s " ..."]]

The drug combination of ledipasvir and sofosbuvir (trade name Harvoni) has been available since November 2014 for the treatment of ...

The European Medicines Agency (EMA) receives comprehensive clinical study data from drug manufacturers. These data form the basis for the ...

15 Juen 2015 - Since February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision ...

Since 2014 dulaglutide has been approved alone or in combination with other drugs for the treatment of adults with type ...

The drug lurasidone (trade name Latuda) has been available since November 2014 for the treatment of adults with schizophrenia. The ...

IQWiG has announced that it has commenced its assessment of the following medicines: ...

The Institute for Quality and Efficiency in Health Care (IQWiG) investigated in a dossier assessment whether propranolol offers an added ...

[:content [\P \e \r \t \u \z \u \m \a \b \space \( \P \e \r \j \e \t \a \) \  \w \a \s \space \l \a \u \n \c \h \e \d \space \i \n \space \G \e \r \m \a \n \y \space \i \n \  \M \a \r \c \h \space \2 \0 \1 \3 \space \f \o \r \space \u \s \e \  \a \s \space \a \d \j \u \n \c \t \i \v \e \space \t \h \e \r \a \p \y \space \b \y \space \c \e \r \t \a \i \n \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \a \d \v \a \n \c \e \d \  \H \E \R \2 \- \p \o \s \i \t \i \v \e \space \b \r \e \a \s \t \space \c \a \n \c \e \r \. \  " ..."]]